Prometheus | Jotup

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates TESS, RXDX, STSA, CHRA

Retrieved on:

Tuesday, April 18, 2023

Prometheus, Sale, Charah, Advertising, OTC, Lee Equity Partners, Fraud, Security (finance), Merck

If you are a TESSCO shareholder, click here to learn more about your rights and options .

Key Points:

If you are a TESSCO shareholder, click here to learn more about your rights and options .
If you are a Prometheus shareholder, click here to learn more about your rights and options .
Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Grafana Labs Announces Grafana Cloud is Now Available in AWS Marketplace

Retrieved on:

Tuesday, April 18, 2023

Technology, Software, Cloud, Loki, Prometheus, Amazon Web Services, Alibaba Cloud, Amazon Elastic Compute Cloud, Blog, Amazon Redshift, GB, Cloud computing, Cloud analytics, Corporation, Kushki, AWS, Corporate development, Online shopping, Grafana

Grafana Labs, the company behind the world’s most ubiquitous open and composable operational dashboards, today announced the availability of the full LGTM stack on Grafana Cloud in AWS Marketplace .

Key Points:

Grafana Labs, the company behind the world’s most ubiquitous open and composable operational dashboards, today announced the availability of the full LGTM stack on Grafana Cloud in AWS Marketplace .
AWS customers can now easily deploy a fully managed Grafana LGTM Stack on Grafana Cloud (Grafana Loki for logs, Grafana for visualizations, Grafana Tempo for tracing, and Grafana Mimir for Prometheus metrics).
Along with AWS Marketplace , Grafana Cloud is available through Microsoft Azure Marketplace and Google Marketplace .
To get started, users can sign up for Grafana Cloud in AWS Marketplace or contact their Grafana Labs account manager.

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates RXDX, STSA, CHRA

Retrieved on:

Monday, April 17, 2023

Prometheus, Sale, Charah, Fraud, Advertising, CHRA, OTC, Security (finance), Merck

If you are a Prometheus shareholder, click here to learn more about your rights and options .

Key Points:

If you are a Prometheus shareholder, click here to learn more about your rights and options .
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

RXDX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Prometheus Biosciences, Inc. is Fair to Shareholders

Retrieved on:

Sunday, April 16, 2023

Class Action Lawsuit, Professional Services, Legal, Fraud, Advertising, Sale, Security (finance), Prometheus, Merck

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Prometheus Biosciences, Inc. (NASDAQ: RXDX) to Merck for $200.00 per share in cash is fair to Prometheus shareholders.

Key Points:

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Prometheus Biosciences, Inc. (NASDAQ: RXDX) to Merck for $200.00 per share in cash is fair to Prometheus shareholders.
On behalf of Prometheus shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.
Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

Retrieved on:

Sunday, April 16, 2023

RAHWAY, N.J. and SAN DIEGO, April 16, 2023 (GLOBE NEWSWIRE) -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. (“Prometheus”) (Nasdaq: RXDX) today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion.

Key Points:

“The agreement with Prometheus will accelerate our growing presence in immunology where there remains substantial unmet patient need.
“Prometheus was established to revolutionize the treatment of immune-mediated diseases through the application of a powerful precision medicine approach,” said Mark McKenna, chairman and chief executive officer of Prometheus Biosciences.
Morgan Stanley & Co. LLC acted as financial advisor to Merck in this transaction and Paul, Weiss, Rifkind, Wharton & Garrison LLP as its legal advisors.
Centerview Partners LLC and Goldman Sachs & Co. LLC acted as financial advisors to Prometheus and Latham & Watkins LLP as the company’s legal advisor.

Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

Retrieved on:

Sunday, April 16, 2023

“The agreement with Prometheus will accelerate our growing presence in immunology where there remains substantial unmet patient need.

Key Points:

“The agreement with Prometheus will accelerate our growing presence in immunology where there remains substantial unmet patient need.
“Prometheus was established to revolutionize the treatment of immune-mediated diseases through the application of a powerful precision medicine approach,” said Mark McKenna, chairman and chief executive officer of Prometheus Biosciences.
Morgan Stanley & Co. LLC acted as financial advisor to Merck in this transaction and Paul, Weiss, Rifkind, Wharton & Garrison LLP as its legal advisors.
Centerview Partners LLC and Goldman Sachs & Co. LLC acted as financial advisors to Prometheus and Latham & Watkins LLP as the company’s legal advisor.

Fiberplane's New Autometrics Puts Observability Metrics in Developers's Hands, Unlocks New Level of Insight in Production

Retrieved on:

Thursday, April 13, 2023

DevOps, Prometheus, GitHub, Integrated development environment, Developer, Workflow, Observability, Confusion, Ides, YAML, IDE, Cassette tape, Online shopping, Rare-earth element, Autometric

AMSTERDAM, April 13, 2023 /PRNewswire/ -- Fiberplane, the first real-time collaboration notebook specifically designed for developers and DevOps teams to debug their infrastructure, today announced Autometrics, a powerful set of open source libraries that enables developers to take advantage of an underutilized but powerful tool in the observability stack - metrics.

Key Points:

"Metrics are underused today relative to their power and cost effectiveness because they have a developer experience problem.
"Fiberplane's new Autometrics addresses many of these developer experience problems, ultimately making it easier for them to understand how their code is performing in production."
As a result, few are using and benefiting from the use of metrics in their production environments today.
"With function-level metrics and IDE integration, Autometrics is changing the game for observability, meeting developers where they are."

RTI Introduces New Connext Observability Framework to Maximize the Performance and Availability of Intelligent Systems

Retrieved on:

Wednesday, April 12, 2023

Loki, Prometheus, Communication, RTI, Trust, Patient, DDS, Observability, V&V, Growth, Health, Risk management, Online shopping

SUNNYVALE, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI) , the largest software framework company for autonomous systems, today announced the latest addition to its Connext® Product Suite featuring the Connext Observability Framework .

Key Points:

SUNNYVALE, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI) , the largest software framework company for autonomous systems, today announced the latest addition to its Connext® Product Suite featuring the Connext Observability Framework .
The Observability Framework is the first solution of its kind for operational technology systems based on the DDS standard, extending the reliability, security, performance and resilience inherent in RTI Connext.
The Connext Observability Framework is available with Connext 7.1, the latest release of the Connext Product Suite.
For more information on licensing and pricing of the Connext Observability Framework and Connext 7.1, please contact [email protected] .

BullFrog AI Announces Exclusive, Worldwide Licensing Agreement with Johns Hopkins’ Applied Physics Laboratory for Patented AI Technology

Retrieved on:

Tuesday, April 4, 2023

Prometheus, APL, Communication, Drug development, Failure, Therapy, Applied Physics Laboratory, Patient, Machine learning, Anomaly, Algorithm, Medicine, Benchmarking, Bullfrog, Pharmaceutical industry, Gull

GAITHERSBURG, Md., April 04, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (Nasdaq: BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a digital technology company using machine learning to usher in a new era of precision medicine, is pleased to announce its worldwide license agreement with Johns Hopkins University Applied Physics Laboratory (“APL”) for use of patented technology powering the Company’s bfLEAP™ platform.

Key Points:

GAITHERSBURG, Md., April 04, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (Nasdaq: BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a digital technology company using machine learning to usher in a new era of precision medicine, is pleased to announce its worldwide license agreement with Johns Hopkins University Applied Physics Laboratory (“APL”) for use of patented technology powering the Company’s bfLEAP™ platform.
BullFrog’s bfLEAP™ platform analyzes drug development data to potentially make life-saving therapies and treatments available to patients more quickly.
The innovative technology, which enables the detection of anomalies, patterns, and relationships, has been shown to perform better than well-known algorithms in benchmarking tests.
“With the help of John Hopkins APL’s patented technology, our bfLEAP™ platform is able to overcome these challenges, enabling precise identification of meaningful data for more agile drug development.

Sysdig Achieves Compliance and Auditing and Monitoring and Observability Distinctions in AWS Cloud Operations Competency

Retrieved on:

Thursday, April 6, 2023

Sysdig, a leader in cloud security powered by runtime insights, announced today that it has achieved the Amazon Web Services (AWS) Cloud Operations Competency in the categories of Compliance and Auditing and Monitoring and Observability.

Key Points:

Sysdig, a leader in cloud security powered by runtime insights, announced today that it has achieved the Amazon Web Services (AWS) Cloud Operations Competency in the categories of Compliance and Auditing and Monitoring and Observability.
The new AWS Cloud Operations Competency allows customers to select validated AWS Partners who offer comprehensive solutions with an integrated approach across all five solution areas of Cloud Operations: Cloud Financial Management, Cloud Governance, Monitoring and Observability, Compliance and Auditing, and Operations Management.
As an AWS Cloud Operations Competency Partner, Sysdig has demonstrated expertise in helping customers build a strong and scalable foundation for their end-to-end Cloud Operations.
The AWS Cloud Operations Competency differentiates AWS Partner Network (APN) members with significant expertise in providing cross-functional guidance across the five solution areas of Cloud Operations.